Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1076
Allegiant Air
ALGT
$2.09B
| $9.6M | 0.01% |
174,700
+114,000
| +188% | +$5.88M |
2025 Q1
1 quarter
|
|
1077
Xeris Biopharma Holdings
XERS
$1.91B
| $9.6M | 0.01% |
2,055,340
-107,300
| -5% | -$492K |
2020 Q1
21 quarters
|
|
1078
Federal Agricultural Mortgage
AGM
$2.21B
| $9.58M | 0.01% |
49,334
-2,066
| -4% | -$379K |
2016 Q1
37 quarters
|
|
1079
Protagonist Therapeutics
PTGX
$9.3B
| $9.57M | 0.01% |
173,134
-150,433
| -46% | -$7.22M |
2022 Q1
13 quarters
|
|
1080
Independent Bank
INDB
$3.65B
| $9.55M | 0.01% |
151,839
+33,100
| +28% | +$2.01M |
2021 Q2
16 quarters
|
|
1081
The Kraft Heinz Company
KHC
$26.4B
| $9.54M | 0.01% |
369,400
-1,117,694
| -75% | -$31M |
2025 Q1
1 quarter
|
|
1082
Hilltop Holdings
HTH
$2.08B
| $9.53M | 0.01% |
314,084
+177,300
| +130% | +$5.26M |
2024 Q1
5 quarters
|
|
1083
Douglas Emmett
DEI
$1.64B
| $9.53M | 0.01% |
633,400
+242,100
| +62% | +$3.5M |
2023 Q2
8 quarters
|
|
1084
Huron Consulting
HURN
$2.66B
| $9.5M | 0.01% |
69,058
-15,800
| -19% | -$2.25M |
2017 Q1
33 quarters
|
|
1085
NorthWestern Energy
NWE
$4.56B
| $9.5M | 0.01% |
185,126
+45,400
| +32% | +$2.51M |
2024 Q4
2 quarters
|
|
1086
iQIYI
IQ
$984M
| $9.48M | 0.01% |
+5,357,700
| New | +$9.63M |
2025 Q2
0 quarters
|
|
1087
The RMR Group
RMR
$302M
| $9.48M | 0.01% |
579,914
-32,200
| -5% | -$493K |
2016 Q2
36 quarters
|
|
1088
Ouster
OUST
$2.88B
| $9.47M | 0.01% |
390,600
+318,700
| +443% | +$3.88M |
2025 Q1
1 quarter
|
|
1089
The Greenbrier Companies
GBX
$1.19B
| $9.47M | 0.01% |
205,600
-11,600
| -5% | -$519K |
2024 Q3
3 quarters
|
|
1090
Core Scientific
CORZ
$4.95B
| $9.46M | 0.01% |
554,317
+58,079
| +12% | +$581K |
2024 Q2
4 quarters
|
|
1091
Olin
OLN
$1.7B
| $9.44M | 0.01% |
469,800
+98,500
| +27% | +$2.05M |
2025 Q1
1 quarter
|
|
1092
Excelerate Energy
EE
$1.09B
| $9.43M | 0.01% |
321,500
-3,253
| -1% | -$91.3K |
2022 Q2
12 quarters
|
|
|
BFS
1093
Saul Centers
BFS
$742M
| $9.43M | 0.01% |
276,074
-39,600
| -13% | -$1.34M |
2013 Q2
48 quarters
|
|
1094
Gogo Inc
GOGO
$314M
| $9.41M | 0.01% |
641,000
+18,100
| +3% | +$184K |
2019 Q3
23 quarters
|
|
1095
GCM Grosvenor
GCMG
$807M
| $9.39M | 0.01% |
812,333
+50,333
| +7% | +$623K |
2021 Q2
16 quarters
|
|
1096
Denison Mines
DNN
$2.2B
| $9.38M | 0.01% |
5,152,401
-6,924,521
| -57% | -$10.5M |
2024 Q4
2 quarters
|
|
1097
Navigator Holdings
NVGS
$1.47B
| $9.38M | 0.01% |
662,688
-182,900
| -22% | -$2.46M |
2018 Q1
29 quarters
|
|
1098
Stantec
STN
$7.52B
| $9.35M | 0.01% |
86,000
-24,200
| -22% | -$2.33M |
2013 Q2
48 quarters
|
|
1099
ProShares UltraPro QQQ
TQQQ
$39.5B
| $9.35M | 0.01% |
225,200
+137,200
| +156% | +$4.34M |
2025 Q1
1 quarter
|
|
1100
Douglas Elliman
DOUG
$141M
| $9.33M | 0.01% |
4,023,158
+33,154
| +0.8% | +$70.8K |
2021 Q4
14 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.